CellType
Cambridge, United States· Est.
AI platform that decodes cellular biology to accelerate drug target discovery and cell‑therapy design.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI platform that decodes cellular biology to accelerate drug target discovery and cell‑therapy design.
OncologyImmunologyRare Diseases
Technology Platform
The Biological Reasoning Engine fuses large language models with graph‑neural networks to infer cell‑type identities, functional states, and therapeutic targets from multi‑omics data.
Opportunities
Expanding collaborations with pharma to accelerate cell‑therapy target discovery and launching pre‑validated target libraries for rapid IND initiation.
Risk Factors
Reliance on public omics data quality, competitive pressure from larger AI‑biotech platforms, and translation of computational predictions into clinical success.
Competitive Landscape
CellType competes with AI‑driven discovery firms like Insilico Medicine and DeepMind Health, differentiating through its focus on cellular reasoning and integration of spatial omics.